Table 3.
Occurrence of self-reported systemic inflammatory diseases in the patient cohort and bone loss groups.
| Self-Reported Systemic Inflammatory Diseases | Bone Loss | p-Value | |||
|---|---|---|---|---|---|
| Total Population (n = 4890) |
None to Mild (n = 3837–78.5%) |
Moderate (n = 730–14.9%) |
Severe (n = 323–6.6%) |
||
| Hypertension | 1421 (29.1) | 1000 (26.1) | 291 (39.9) | 130 (40.2) | <0.001 |
| Arthritis | 1054 (21.6) | 777 (20.3) | 209 (28.6) | 68 (21.1) | <0.001 |
| Asthma | 415 (8.5) | 355 (9.3) | 42 (5.8) | 18 (5.6) | 0.001 |
| Diabetes | 516 (10.6) | 348 (9.1) | 115 (15.8) | 53 (16.4) | 0.006 |
| Cancer | 447 (9.1) | 338 (8.8) | 83 (11.4) | 26 (8.0) | 0.07 |
| Irritable bowel syndrome | 191 (3.9) | 158 (4.1) | 26 (3.6) | 7 (2.2) | 0.19 |
| Hepatitis | 96 (2.0) | 70 (1.8) | 21 (2.9) | 5 (1.5) | 0.15 |
| Lupus | 23 (0.5) | 16 (0.4) | 3 (0.4) | 4 (1.2) | 0.11 |
| HIV positive/AIDS | 26 (0.5) | 14 (0.4) | 8 (1.1) | 4 (1.2) | 0.009 |
| Parkinson’s disease | 14 (0.3) | 8 (0.2) | 5 (0.7) | 1 (0.3) | 0.09 |